Anti-arthrosclerosis effects |
Danggui and sodium ferulate |
reverse the reduction of TGB-β/reverse the increase of bFGF [24] |
|
|
|
Danggui |
reduce the increase of serum malonyldialdehyde (MDA) levels [25] |
|
|
|
sodium ferulated |
decrease the levels of triglyceride [11] |
|
Vasodilatation and improving microcirculation effects |
Danggui |
increase the formation of NO and mediate the inhibition of calcium influx [10] |
|
|
|
sodium ferulate |
increase the generation of NO [11] |
|
|
|
Ligustilide |
inhibit prostaglandin F-2α, oxytocin, acetylcholine chloride, and potassium depolarization-induced muscle contraction [12] |
|
|
|
Ligustilide |
increase the number of opened capillary and the speed of blood flow [13] |
|
|
|
Ferulic acid |
enhance acetylcholine-induced vasodilatation and reduce the production of thromboxane B2 [14] |
|
Anti-platelet aggregation effects |
Danggui and sodium ferulate |
inhibit ADP-induced and collagen-induced platelet aggregation [27] |
|
|
|
Z-Ligustilide |
inhibit ADP-induced platelet aggregation [28] |
|
Anti-inflammatory effects |
Ferulic acid |
inhibit ICAM-1 and NF-κB expression [33] |
|
|
|
Ferulic acid |
enhance gamma-aminobutyric acid type B1 (GABAB1) receptor expression [34] |
|
|
|
Danggui |
reduce TNF-α and TGF-ß1 mRNA expression [35] |
|
|
|
Danggui polysaccharides |
reduce TNF-α levels [36] |
|
Anti-oxidative effects |
Ferulic acid |
reduce the generation of NADPH-dependent production of superoxide anion [14] |
|
|
|
Ferulic acid |
enhances the expression of GABAB1 receptor expression [34] |
|
|
|
Z-ligustilide |
reduce MDA levels and increase GSH-PX and SOD activities [42] |